Innoviva, Inc.
Company Stats
- Market Cap
- $1.5B
- as of Sep 30, 2026
- Enterprise Value
- $1.2B
- Shares Outstanding
- 72.2M
- Free Float
- 93.8%
Income Statement
- Revenue
- $411.3M
- Operating Income
- $163.7M
- Net Income
- $271.2M
- Revenue Growth, 3Y
- 7.5%
- FCF Margin, 3Y Avg
- 48.5%
- FCF Margin, Worst Year
- 45.3%
Cash Flow
- Free Cash Flow
- $195.8M
- FCF Yield
- 12.8%
- Owner FCF Yield
- 12.2%
Balance Sheet
- Cash & Equivalents
- $550.9M
- Total Debt
- $257.7M
- Net Cash
- $293.2M
Returns & Capital
- Share Repurchases
- $4.5M
- Buyback Yield, 3Y Avg
- 2.1%
- SBC, 3Y Avg
- $7.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $411.3M | $195.8M | 47.6% |
| FY2024 | $358.7M | $188.4M | 52.5% |
| FY2023 | $310.5M | $140.7M | 45.3% |
| FY2022 | $331.3M | $201.7M | 60.9% |
| FY2021 | $391.9M | $363.8M | 92.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back